This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request. All data needed to evaluate the conclusions in the paper is presented in the paper and/ or the Supporting Information.
References
Kozma K, Dömötör ZR, Csutak A, Szabó L, Hegyi P, Erőss B, et al. Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis. Sci Rep. 2022;12:14221.
Gündüz AK, Mirzayev I, Okcu Heper A, Kuzu I, Gahramanli Z, Cansiz Ersöz C, et al. Anterior segment optical coherence tomography in ocular surface tumours and simulating lesions. Eye. 2023;37:925–37.
Author information
Authors and Affiliations
Contributions
MT: Conceptualization, patient management, manuscript writing, and editing. AM: Literature search, manuscript review.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tripathi, M., Markan, A. Rapid remission of extensive corneal surface neoplasia with topical interferon therapy. Eye (2025). https://doi.org/10.1038/s41433-025-03974-0
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41433-025-03974-0